Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16169,200,4.75 [2.05-10.97],0.0002670481903368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18507,234,0.74 [0.60-0.92],0.0074647193795598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,18398,232,1.67 [1.09-2.58],0.0198048339315739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,18267,228,0.74 [0.58-0.94],0.014508427002613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,15789,194,0.52 [0.34-0.80],0.0031551206750044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15656,189,0.78 [0.67-0.90],0.0005922664573215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15656,189,1.57 [1.09-2.26],0.0151438838696151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,15691,190,2.20 [1.25-3.88],0.0060623873670645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,18596,234,1.88 [1.21-2.90],0.0045578491104416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,15789,194,0.82 [0.67-1.00],0.0499689494433206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,18537,235,1.34 [1.02-1.76],0.0363212974513333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,18560,236,0.83 [0.72-0.96],0.0096460527455019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18829,238,2.01 [1.14-3.54],0.0159171904334112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,18598,236,0.73 [0.58-0.93],0.0098171542319467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,18745,235,2.43 [1.41-4.20],0.0014147264070348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16150,196,1.82 [1.05-3.14],0.0332412683209675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,16110,194,0.78 [0.64-0.94],0.0113556004419519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18629,232,1.48 [1.06-2.08],0.0231326394620412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,18663,234,1.62 [1.08-2.41],0.0186390627844221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,18178,232,0.75 [0.58-0.97],0.0308353565237517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15580,187,0.80 [0.65-0.99],0.0388036593954998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,15653,191,1.21 [1.02-1.44],0.0257279240079348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,16007,194,1.34 [1.02-1.76],0.0368405335344107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16164,199,1.67 [1.03-2.70],0.0368210287183876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,18178,232,0.76 [0.62-0.94],0.0106907057849614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18686,235,2.00 [1.32-3.02],0.0009821661779056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18657,235,1.58 [1.05-2.37],0.0285733927959405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,18178,232,1.77 [1.23-2.54],0.0021541468030137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,18598,236,0.81 [0.67-0.97],0.0203220398690609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,15789,194,1.68 [1.04-2.71],0.0344719211326937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18200,231,1.31 [1.02-1.69],0.0364316902444805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,15653,191,1.37 [1.04-1.80],0.0263947381651478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,16120,197,1.43 [1.01-2.02],0.0429332643019125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,16134,200,3.18 [1.55-6.53],0.0016172182509597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,16169,200,2.73 [1.53-4.86],0.0006726170774279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2,Complement C2,18663,234,3.10 [1.70-5.67],0.0002385449773783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,18172,231,1.36 [1.07-1.73],0.0132715487689255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,18640,235,1.59 [1.19-2.14],0.0017930778800645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,16090,198,0.83 [0.69-0.98],0.0293313209544888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,18232,229,0.72 [0.59-0.89],0.0020767888690477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,18540,236,0.78 [0.66-0.93],0.0058458398380631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,18804,238,0.75 [0.61-0.92],0.0056530392056348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,18539,235,0.78 [0.65-0.94],0.0090863900153534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,15730,191,1.41 [1.07-1.86],0.0156596327997014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18532,233,1.78 [1.00-3.16],0.0498718893806838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,18200,231,0.69 [0.54-0.88],0.003188909792356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,18200,231,1.20 [1.03-1.39],0.0199586874191634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAT,Catalase,15931,198,0.73 [0.56-0.96],0.0235500506047783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18570,232,1.58 [1.23-2.03],0.0002928449192236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18380,235,1.29 [1.04-1.60],0.0193471599555252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18792,238,1.92 [1.42-2.61],2.270772999756979e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18257,230,1.57 [1.19-2.06],0.0014759964391154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18819,237,1.27 [1.01-1.61],0.0419582905127962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18686,235,1.32 [1.01-1.71],0.0398194496915263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18640,235,2.00 [1.24-3.24],0.0046890159024871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18526,236,1.48 [1.08-2.02],0.0155515841032713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18178,232,1.35 [1.00-1.82],0.0480532412630062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18716,234,1.33 [1.02-1.74],0.0353913148850574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18771,235,1.33 [1.08-1.63],0.0077697198987855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16144,199,1.53 [1.04-2.25],0.0317435390481038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,16090,198,1.75 [1.12-2.75],0.013980909774503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18763,237,1.30 [1.05-1.60],0.0172660640912504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17919,224,1.53 [1.06-2.21],0.0231863994618193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,17997,229,1.45 [1.13-1.86],0.0033625870352214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,18596,234,1.41 [1.03-1.93],0.0305073585547745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16090,198,0.70 [0.50-0.99],0.0411789440239541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,15893,194,1.58 [1.03-2.42],0.0365822913315454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,15251,180,2.01 [1.08-3.72],0.0265397822671447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,16134,199,1.29 [1.05-1.58],0.0139944059876871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,16169,200,3.13 [1.56-6.30],0.0013466102474356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFP,Properdin,16169,200,2.00 [1.32-3.05],0.0012083352148849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18598,236,1.41 [1.20-1.66],2.753266247532762e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,15730,191,1.43 [1.05-1.94],0.0229150833051565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18178,232,0.80 [0.64-0.99],0.0378117075160228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,16150,196,1.16 [1.02-1.32],0.0292410191531117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,18596,234,0.75 [0.58-0.96],0.0245865074704817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,18592,236,1.51 [1.07-2.13],0.0202982372846181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,15730,191,1.61 [1.26-2.07],0.0001489205326114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18771,235,1.84 [1.12-3.02],0.0156416237686703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,15730,191,0.48 [0.30-0.76],0.0015522154994394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,18819,237,0.72 [0.53-0.98],0.0385842737976832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18686,235,1.48 [1.13-1.95],0.0043258560921075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15653,191,1.30 [1.06-1.58],0.0102771356103689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,18829,238,1.82 [1.14-2.89],0.0119707074084757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18829,238,1.38 [1.03-1.85],0.0327125985611706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15865,196,0.52 [0.35-0.77],0.0012506151542479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18567,235,1.56 [1.04-2.34],0.031943995263028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,16144,200,2.85 [1.56-5.20],0.0006214197113382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,16144,199,1.85 [1.12-3.06],0.016748174001025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,18567,235,2.11 [1.38-3.23],0.0006172461484172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,18070,228,1.22 [1.03-1.45],0.0197224459850322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18657,235,1.82 [1.20-2.74],0.0044648263865536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15614,190,0.83 [0.71-0.98],0.0237845411159612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,18121,232,0.67 [0.53-0.85],0.00082466140328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,18599,235,1.12 [1.01-1.25],0.0355641366079072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,18205,228,1.23 [1.05-1.44],0.0091426886770126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18701,234,0.73 [0.55-0.99],0.0417293370837666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,18286,230,0.71 [0.53-0.97],0.0297175581077922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18819,237,1.30 [1.00-1.69],0.0465513094113774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,15789,194,0.79 [0.65-0.95],0.0120455888687518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,15656,189,1.25 [1.00-1.55],0.0467014484649227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15653,191,0.68 [0.48-0.97],0.0318040617794375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18640,235,2.02 [1.42-2.88],9.48228680130396e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,16110,194,0.76 [0.63-0.93],0.0063775522084993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18719,234,1.21 [1.01-1.45],0.0350561671250183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18368,235,1.43 [1.04-1.98],0.029867949150748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,15730,191,0.76 [0.59-0.97],0.0305839398282839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18267,228,1.54 [1.13-2.09],0.0062082300870223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18567,236,1.58 [1.10-2.27],0.0139170974581002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18829,238,2.16 [1.06-4.41],0.0341436607121299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18596,234,0.77 [0.64-0.94],0.0085049975508787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELN,Elastin,16144,199,1.57 [1.07-2.30],0.0218879196411178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,14900,189,0.70 [0.55-0.90],0.0054384281741083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18829,238,1.62 [1.03-2.53],0.0350578913106131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15691,190,0.75 [0.58-0.98],0.0364838874100365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17944,223,1.76 [1.26-2.46],0.0009824191633877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18829,238,1.58 [1.03-2.41],0.0357211091140056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,18505,235,2.66 [1.55-4.57],0.0003645598318285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,18640,235,1.76 [1.08-2.85],0.0222181725817865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,16164,199,1.56 [1.11-2.20],0.0105929472880634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,15942,198,1.78 [1.34-2.38],8.85279178798964e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,16101,200,1.89 [1.10-3.26],0.021379830546695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,16169,200,3.38 [1.37-8.37],0.008456561119046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,18657,235,2.21 [1.49-3.26],6.843928219039411e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,18663,234,2.26 [1.21-4.23],0.011012762829508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18829,238,1.27 [1.02-1.57],0.0338104733042759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,18592,236,0.64 [0.52-0.80],5.60502006604333e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18630,235,1.32 [1.03-1.69],0.0277533987721666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,18533,230,1.46 [1.07-1.99],0.0157552603564634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18596,234,1.32 [1.02-1.70],0.0336876095554852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,18663,234,3.15 [2.11-4.70],2.1938000154887096e-08
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18592,236,0.83 [0.70-0.99],0.0373315383147221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,18640,235,1.62 [1.13-2.31],0.0083298709266941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18763,237,1.69 [1.14-2.50],0.0084026205923743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15691,190,1.46 [1.14-1.87],0.0030700705710657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,16072,194,0.83 [0.69-0.98],0.0332105255486537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,18657,235,0.82 [0.69-0.98],0.0276196029486874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,15865,196,1.34 [1.10-1.63],0.0038975682699288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,15614,190,1.65 [1.20-2.27],0.0021980199242957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18596,234,1.63 [1.18-2.25],0.0031508850388885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18748,235,1.92 [1.33-2.77],0.0004920345383951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,18302,232,1.53 [1.10-2.12],0.010774206774853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,18474,232,0.79 [0.64-0.98],0.0350049122635199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,18819,237,0.76 [0.61-0.96],0.021427876072648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18763,237,1.64 [1.07-2.51],0.022593216352159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",16150,196,0.61 [0.43-0.88],0.007139227775321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,18592,236,0.83 [0.68-1.00],0.0487929597156204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18722,235,0.76 [0.64-0.90],0.0014135527800664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,18745,235,1.26 [1.06-1.50],0.0094529620844607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18598,236,1.41 [1.03-1.92],0.032745285393943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,15656,189,0.68 [0.50-0.93],0.0141719355586898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18592,236,1.45 [1.00-2.09],0.0481010000080012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,18771,235,0.65 [0.49-0.86],0.0023370695820671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,15653,191,1.31 [1.00-1.71],0.0461384409877183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18829,238,2.15 [1.33-3.48],0.0018063970645918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18537,231,1.49 [1.01-2.20],0.0469231348782143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18829,238,1.45 [1.02-2.07],0.0411118920377113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18657,235,1.76 [1.07-2.90],0.0252418819340645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,18686,235,2.66 [1.81-3.91],7.0750131500325e-07
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,18354,233,1.79 [1.10-2.92],0.0198822234540397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,18598,236,1.37 [1.05-1.79],0.0194411780669924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18686,235,1.64 [1.15-2.32],0.0056408949427064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18567,236,1.82 [1.14-2.91],0.0124227271207651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18598,236,1.31 [1.02-1.67],0.0310830439313656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,18769,238,0.68 [0.54-0.87],0.0022924055569745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18482,236,1.36 [1.03-1.79],0.030543628274287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18512,231,1.42 [1.01-2.00],0.044423463596232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,16110,194,0.77 [0.60-1.00],0.0460105820391304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,16110,194,0.70 [0.61-0.80],6.442641432485312e-07
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,16083,195,0.60 [0.42-0.87],0.006360133516003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18592,236,0.66 [0.47-0.93],0.0159880393631611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18686,235,1.49 [1.09-2.03],0.0119115517938191
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16169,200,2.34 [1.43-3.82],0.0006950959940748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18640,235,2.85 [1.77-4.58],1.486907294201734e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,16120,197,0.67 [0.48-0.92],0.0142654154241369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,16052,195,1.37 [1.06-1.77],0.0166276122224531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,16150,196,0.44 [0.39-0.51],4.1756530652378705e-34
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18771,235,1.44 [1.24-1.67],1.4525518364950654e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,15850,196,2.74 [1.54-4.87],0.0005742671440643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15653,191,1.27 [1.06-1.52],0.0086562126857146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,16110,194,1.39 [1.07-1.81],0.0144537855100845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18565,234,0.80 [0.65-0.99],0.044319143018205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,15691,190,1.67 [1.05-2.65],0.0309394491974726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,18035,228,2.15 [1.19-3.88],0.0107637366564245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,18686,235,1.39 [1.14-1.69],0.0010572371978917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,18646,237,1.33 [1.06-1.67],0.0137539529449404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,16144,199,1.24 [1.01-1.52],0.0356818106640408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18596,234,1.47 [1.24-1.75],8.75353866034322e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,16169,200,1.59 [1.07-2.35],0.0206941275402938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18594,235,0.82 [0.68-0.99],0.0426895719975782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18598,236,1.39 [1.00-1.94],0.0484975040219722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18575,233,1.65 [1.15-2.35],0.006224196025227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18829,238,1.72 [1.13-2.62],0.0119118180827209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18738,237,1.65 [1.16-2.34],0.0051153418281052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,15691,190,1.29 [1.04-1.60],0.0226127150819912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,16110,194,1.79 [1.20-2.68],0.0045500875924841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18507,234,1.32 [1.01-1.72],0.0416965307528517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,16090,198,1.56 [1.14-2.14],0.0055531865695518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,16144,199,1.33 [1.02-1.73],0.0328877365576202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LXN,Latexin,18364,234,0.81 [0.67-0.97],0.0201254015133195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16169,200,2.74 [1.42-5.31],0.0027468778831175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,18829,238,0.75 [0.60-0.94],0.0113155448764933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,18748,235,0.80 [0.65-0.98],0.0343496478261969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,18507,234,0.82 [0.70-0.97],0.0170109574724494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,18200,231,1.54 [1.07-2.20],0.0194983507953397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,18598,236,0.65 [0.51-0.83],0.0004156527484004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",18200,231,1.55 [1.10-2.19],0.0114074423259843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,18575,231,0.50 [0.42-0.58],1.8695944771415042e-18
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,18763,237,1.31 [1.02-1.68],0.033098494433226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18640,235,1.52 [1.01-2.30],0.0451738956817628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18640,235,1.60 [1.17-2.18],0.0032710748561737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18829,238,2.19 [1.08-4.45],0.0299221320451847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,16150,196,0.44 [0.29-0.65],5.605285174864832e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18598,236,1.56 [1.05-2.31],0.0280765010954158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18763,237,1.72 [1.01-2.95],0.0471965028479858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18507,234,0.80 [0.64-1.00],0.0490117617105767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,18388,233,0.76 [0.63-0.93],0.0064801812983208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18598,236,1.56 [1.22-2.01],0.0004445070037238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,18507,234,0.80 [0.68-0.95],0.0105838875809396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,16106,198,2.46 [1.29-4.69],0.0060197240424421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18719,235,2.38 [1.33-4.26],0.0035970992340603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,15992,197,1.61 [1.10-2.36],0.0139711286677771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18598,236,2.03 [1.30-3.17],0.0017863511211601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,18286,230,0.78 [0.61-1.00],0.0496706615154589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,18178,232,1.75 [1.15-2.66],0.0092874824896322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18481,234,0.85 [0.73-1.00],0.0450281027794809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18592,236,0.81 [0.66-0.98],0.0299115314581436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18602,235,0.79 [0.65-0.95],0.0104999254523218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",16110,194,0.72 [0.57-0.90],0.0040879743555711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15730,191,1.35 [1.08-1.69],0.009626069515866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,16110,194,1.18 [1.00-1.39],0.0499321965386021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,15656,189,0.71 [0.51-0.97],0.0299368834624875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,18507,234,0.69 [0.57-0.84],0.0002101597024469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18178,232,1.29 [1.11-1.50],0.001234397865043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,18072,232,0.85 [0.74-0.98],0.0271560481474679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,15899,194,0.76 [0.60-0.96],0.0190438632537921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,16110,194,1.65 [1.27-2.15],0.0001795518306711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,18663,234,2.48 [1.57-3.90],9.230800780426998e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18592,236,0.63 [0.50-0.80],0.0001666145984529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,16169,200,1.92 [1.15-3.19],0.0122769126569105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18507,234,0.75 [0.60-0.94],0.0116663379068045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,18368,230,0.69 [0.49-0.97],0.0322955821158296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18592,236,0.73 [0.58-0.92],0.0086656226304013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,18829,238,1.52 [1.02-2.26],0.0376519043914307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16169,200,1.52 [1.07-2.15],0.0204813342451512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,18200,231,1.26 [1.02-1.55],0.0340116084479682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18286,230,0.77 [0.62-0.95],0.0142760442825505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18719,235,1.50 [1.22-1.86],0.0001407699596518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,18175,232,0.74 [0.60-0.92],0.0061328105191269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18506,230,1.27 [1.03-1.58],0.0274990507993295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,18597,235,1.38 [1.12-1.70],0.0028885896630826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REN,Renin,18596,234,0.84 [0.73-0.96],0.0135336123142937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18763,237,1.43 [1.00-2.04],0.048749793827108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,18722,235,0.79 [0.64-0.96],0.0179365662867474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,15765,194,0.45 [0.33-0.61],1.8291175366816619e-07
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,18763,237,1.71 [1.06-2.76],0.02669286472264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18771,235,1.39 [1.00-1.94],0.0486394704921639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,18640,235,0.80 [0.65-0.98],0.0345858366223552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,15653,191,1.31 [1.05-1.65],0.0191681992375796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,15865,196,0.76 [0.60-0.97],0.0290991381028174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,15653,191,1.29 [1.02-1.64],0.0371077337604832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,16144,199,1.53 [1.00-2.34],0.0497121854396033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18592,236,0.58 [0.40-0.84],0.0037162851489471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18596,234,1.65 [1.07-2.53],0.0221942089179008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,15865,196,1.26 [1.03-1.53],0.023080298681478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,18829,238,1.51 [1.14-2.01],0.0041026819066332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,16126,200,2.85 [1.43-5.67],0.0028878861376683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,15931,197,1.52 [1.03-2.24],0.0344851410709384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16169,200,2.58 [1.08-6.14],0.0323061835589662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,18267,228,1.39 [1.09-1.78],0.0090460177435742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,16144,200,4.54 [1.89-10.89],0.0007136875894529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,16144,200,1.95 [1.21-3.14],0.0061468666524178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,15928,195,2.02 [1.23-3.32],0.0052381699688466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,15861,195,6.23 [2.38-16.29],0.0001912353076987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,16144,200,2.92 [1.41-6.03],0.0038340758212352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18657,235,1.42 [1.08-1.86],0.0110012463327366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18592,236,1.45 [1.03-2.04],0.0312968161296255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18745,235,1.52 [1.03-2.25],0.0347396655640121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,18267,228,1.71 [1.25-2.35],0.0007402098623523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,16090,198,0.65 [0.44-0.95],0.0253821420880014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,18689,235,0.76 [0.65-0.89],0.0006182552718725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,16090,198,0.76 [0.71-0.82],2.0257651429758642e-13
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,18597,235,1.41 [1.01-1.98],0.0425198603765812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18686,235,1.48 [1.13-1.95],0.0050477664983658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18829,238,1.60 [1.16-2.21],0.0039783355102919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,18200,231,0.68 [0.50-0.91],0.0096874031936253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15730,191,0.64 [0.51-0.81],0.0001859320440455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18604,235,1.32 [1.00-1.75],0.0489638296172881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,18570,232,1.64 [1.22-2.22],0.0012242802301649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18586,235,1.37 [1.09-1.74],0.0077341717667225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18687,235,1.51 [1.13-2.02],0.0049018807180528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,16083,195,1.19 [1.05-1.34],0.0050902063087736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18640,235,1.72 [1.28-2.31],0.0003286712335228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18564,234,0.82 [0.71-0.96],0.0127242669915197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18596,234,1.44 [1.00-2.08],0.0495369389733526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18686,235,1.58 [1.21-2.06],0.0008011840774103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18545,232,1.73 [1.02-2.92],0.0412465382662145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18598,236,1.51 [1.07-2.13],0.0181925628638745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18598,236,1.33 [1.03-1.72],0.0260965016316134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18763,237,1.71 [1.16-2.54],0.0071665637094336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18447,234,1.51 [1.17-1.96],0.0017621201779053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18819,237,1.61 [1.02-2.54],0.0425985740271593
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18798,238,1.63 [1.11-2.39],0.0121515560695203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18447,234,1.35 [1.03-1.77],0.0273968450931872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,18592,236,0.80 [0.67-0.96],0.0154535308730408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15865,196,1.18 [1.03-1.37],0.0214236861364985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18567,235,1.34 [1.09-1.65],0.0063096748835786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,18592,236,0.85 [0.73-1.00],0.0438500577779204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,18267,228,0.46 [0.37-0.58],8.218208490215568e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,18596,234,1.53 [1.01-2.31],0.0430105220598737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18507,234,0.60 [0.42-0.85],0.0042353609603681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18447,234,1.49 [1.13-1.96],0.0048970345780639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,15730,191,0.77 [0.61-0.97],0.0288779868399892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,18325,231,1.84 [1.21-2.81],0.0045866591465479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,15580,187,1.17 [1.02-1.34],0.02726221652301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,16083,195,1.25 [1.04-1.50],0.0164988692750177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18267,228,1.22 [1.03-1.44],0.0245642014533264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18178,232,2.28 [1.64-3.18],1.0483083121451809e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,15580,187,0.78 [0.62-0.99],0.0441201946568145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,18384,233,1.51 [1.14-2.01],0.0043253492070508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,18736,235,0.72 [0.59-0.87],0.000544549840704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,15614,190,0.74 [0.59-0.94],0.0117743787343337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15580,187,0.49 [0.27-0.89],0.0189791561257527
